Skip to Content

CareDx Inc CDNA

Morningstar Rating
$12.01 +1.37 (12.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CDNA is trading at a 44% discount.
Price
$12.02
Fair Value
$59.25
Uncertainty
Extreme
1-Star Price
$84.18
5-Star Price
$1.44
Economic Moat
Npshk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CDNA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$10.64
Day Range
$10.8812.83
52-Week Range
$4.8016.25
Bid/Ask
$11.80 / $12.24
Market Cap
$649.72 Mil
Volume/Avg
2.4 Mil / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.30
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
4.24%

Company Profile

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
738

Comparables

Valuation

Metric
CDNA
FTRE
VCYT
Price/Earnings (Normalized)
1,617.25
Price/Book Value
2.491.981.68
Price/Sales
2.301.124.83
Price/Cash Flow
16.2236.03
Price/Earnings
CDNA
FTRE
VCYT

Financial Strength

Metric
CDNA
FTRE
VCYT
Quick Ratio
3.671.494.22
Current Ratio
4.021.624.74
Interest Coverage
0.44−3,068.28
Quick Ratio
CDNA
FTRE
VCYT

Profitability

Metric
CDNA
FTRE
VCYT
Return on Assets (Normalized)
−6.76%4.39%2.88%
Return on Equity (Normalized)
−9.03%8.82%3.09%
Return on Invested Capital (Normalized)
−10.48%9.10%2.63%
Return on Assets
CDNA
FTRE
VCYT
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncMnjh$219.8 Bil
DHR
Danaher CorpKbgvm$189.3 Bil
IDXX
IDEXX Laboratories IncHffpp$47.9 Bil
IQV
IQVIA Holdings IncTlljwkg$45.9 Bil
A
Agilent Technologies IncMnv$40.8 Bil
MTD
Mettler-Toledo International IncGgtlcbm$27.2 Bil
ICLR
Icon PLCQzljpn$26.9 Bil
ILMN
Illumina IncVcsbp$22.3 Bil
WAT
Waters CorpDthwx$20.5 Bil
LH
Laboratory Corp of America HoldingsPtbtpx$18.3 Bil

Sponsor Center